Photoacoustic flow cytometry

Last updated

Photoacoustic flow cytometry or PAFC is a biomedical imaging modality that utilizes photoacoustic imaging to perform flow cytometry. A flow of cells passes a photoacoustic system producing individual signal response. Each signal is counted to produce a quantitative evaluation of the input sample.

Contents

Description

Traditional flow cytometry uses cells in a laminar single file stream which then passes through a light source. Using various quantification of light scattering from the cells enables the system to quantify cellular size and complexity which can ultimately be returned in a quantification of cell composition within a sample. Photoacoustic flow cytometry operates on similar principles, but utilizes a photoacoustic signal to differentiate cellular patterns. Furthermore, flow cytometry provides great ex-vivo analysis, but due to its pure optical source its penetration depth is limited making in-vivo analysis limited. Alternatively, photoacoustics may provide an advantage over flow cytometry as it receives an acoustic signal rather than an optical one and can penetrate to greater depths as discussed further in operating principles and mathematics.

The photoacoustic (PA) affect was discovered by Alexander Bell in 1880, occurs when a photon source is absorbed by an optically receptive substance producing an ultrasonic wave. [1] The strength of the ultrasonic wave produced is a function of intensity of photon absorbed, and the innate properties of the substance illuminated. [2] Each substance of interest absorbs photons at a specific wavelength, as a result only certain substances will innately produce a PA signal at a given wavelength. For example, hemoglobin and melanin are two common biological substances that produce strong PA signals in response to laser pulses around the 680 nm wavelength range. [3] The absorption spectrum for the PA lies within the visible electromagnetic spectrum, making PA imaging non-radiative in nature. The specific absorption spectrum can both be a limitation and an exploitation of PA imaging (see more in applications).

Systems commonly use an Nd:YAG (neodymium-doped yttrium aluminum garnet) or LED laser system that is pulsed to penetrate the biological tissue of interest. [4] [5] With each pulse that comes in contact with tissue, a PA signal in the form of an ultrasound wave is produced. This ultrasound wave propagates through the tissue until it reaches an ultrasound transducer to produce an a-line. The maximum amplitude of each a-line is extracted and its value is plotted on a time vs amplitude graph producing a cytometry graphic .

Operating principles and mathematics

Heat production

Photoacoustic flow cytometry operates on the principle of the photoacoustic effect, whereby a laser in the visible spectrum produces a temperature rise and thus a thermal expansion. The thermal expansion equation with relation to laser intensity for a pulsating laser is described below. [2]

Where is the absorption coefficient of the focused equation, is the intensity of the laser, ⍵ is the frequency of the laser pulse, t is time. is described as the exponential expression of a sinusoidal function determined by Euler's formula. It is important to note that the penetration depth of the laser is limited by the diffusive regime, which is dependent on the attenuation through the tissue prior to biological target to be irradiated.

Photoacoustic wave relationship

Below then establishes the heat-pressure relationship for a photoacoustic signal. [2]

Where ∇ is the partial differential equation set with spatial relationship, is the speed of sound in the substance of interest, t is time, is pressure as a function of both time and space, β is the thermal expansion coefficient, is the specific heat capacity, and is the partial differential of the heat equation described above.

The left side of the equation describes the pressure wave equation which is derived for modeling of an ultrasonic pressure wave equation. The right side of the equation determines the relationship of heat production to thermal expansion resulting in a pressure wave.

Pressure wave solution

While reality produces a three dimensional wave that propagates through the tissue, for the purposes of PAFC, the information needed only pertains to a one dimensional analysis. Below demonstrates the one dimensional solution due to a pulsed laser. [2]

Where is the absorption coefficient, is the thermal expansion coefficient, is the specific heat, F is the fluence of the laser, is the speed of sound in a given material and is the total energy derived from the laser pulse.

It is important to note that for long durations of laser exposure, the wave equation becomes largely a function of laser intensity. For the purposes of analyzing PA signal, the laser pulse must be short in time to produce a signal that its value varies on the properties of the irradiated substance to differentiate the targets of interest. The differences in the pressure wave produced is the basis for signal separation in PAFC.

Signal detection

Example PAFC where red cells produce a red signal of smaller amplitude. Counting the blue amplitudes shows one blue cell within the sample PAFC Animation.gif
Example PAFC where red cells produce a red signal of smaller amplitude. Counting the blue amplitudes shows one blue cell within the sample

The pressure wave created is in the form of an ultrasound wave. The wave propagates through the material and is detected by an ultrasound transducer. The pressure is sensed via piezoelectric crystals which converts the pressure into a voltage change, i.e. , the amplitude of the signal is proportional to the value of the pressure at any given time. This voltage is plotted as a function of time and results in the formation of an a-line previously described.

The temporal data is important for other types of photoacoustic imaging, but for the purposes of PAFC, the maximum amplitude within an a-line is extracted as the data point. For each laser pulse this maximum amplitude value is plotted vs time producing a flow cytometry signal tracing. Each line represents a laser pulse and its amplitude reflects the target irradiated. By selecting an amplitude range that is representative of a particular cell type, the signals can be counted and thus quantify cell types within a given sample. Figure 1 shows an animation of cells flowing and its representative PAFC signal tracing.

Applications

Bacteria

Over two million bacterial infections occur annually in the United States. [6] With antibiotic resistance increasing treatment of these infections is becoming increasingly difficult making correct antibiotic selection evermore important. Optimal antibiotic selection hangs on the ability to determine the offending bacteria. Traditionally, bacterial speciation is determined by culturing and PCR technologies. These technologies take at least 48 hours and sometimes more. Due to the prolonged timeframe for speciation, providers must select broad-spectrum antibiotics. PAFC can be used to detect bacteria in the blood for more timely antibiotic selection.

The first step in detection with PAFC is marking the bacteria so they have a PA signal to detect. Typically, this is composed of a dye of and a method to attach the dye to the bacteria of interest. Although antibodies have been used in the past, bacteriophages have proven to be cheaper and more stable to produce. [7] Multiple studies have shown the specificity of bacteriophage selection for a bacteria of interest, particularly MRSA, E. Coli , and Salmonella . [8] [7] [9] Dyes vary, but most commonly utilized are gold nanoparticles, Indocyanine green (ICG), and red dye 81. [7] [9] The dyes produce an enhanced signal to enable more sensitive detection. The detection limits found in one study showed approximately 1 bacterial cell per 0.6 μm3. [9] Specific dyes have been tested on animals for toxicity and have not resulted in any clear damage. Although human studies for the detection of bacteria in the blood have yet to be attempted, PAFC may play a role in future applications of bacterial detection.

Malaria

Malaria causes the deaths of 0.4 million people yearly worldwide. [10] With current medications, early detection is key to preventing these deaths. Current methods include microscopic detection on blood film, serology, or PCR. [11] Lab technicians may lack the experience or the technologies may be too expensive for certain facilities, inevitably missing the diagnosis. Furthermore current methods generally cannot detect malaria at parasites < 50 per microliter and needs 3–4 days post infection before detection can occur. [12] Thus, there is a need for a more automated and sensitive detection method to improve patient outcomes.

PAFC has proven detection limits at much lower than current methods. One study demonstrated a sensitivity of one parasite in 0.16 mL of circulating blood and thus can be detected on day 1–2 post inoculation. [12] Furthermore, studies have demonstrated the feasibility of in vivo detection removing the possibility of missed diagnosis from damaged cells from blood extraction and in-vitro analysis. [13] PAFC detects malaria via the surrogate marker hemozoin, a breakdown product produced by malaria in the merozoite stage. Hemozoin is a great photoacoustic target and responds strongly at wavelengths 671 nm and 820 nm range. [12] Although background signals are produced by hemoglobin within RBCs, infected RBCs (iRBCs) with hemozoin produce a strong signal above hemoglobin at these wavelengths. In vitro methods utilize 50 micrometer capillary tubes with flow of 1 cm/s (in vitro) for detection. Conversely, Menyaev et al. demonstrated the detection of malaria in vivo. [13] Detection was performed on superficial and deep vessels of mice. The superficial vessels provide a higher signal-to-noise ratio (SNR), but are less comparable to that of human vessels. Mice jugular veins and carotid arteries are similar in size to small human vessels which demonstrated higher artifacts due to blood pulsation and respiratory variation, but could be accounted for.

Although PAFC provides a more sensitive detection limit, this method does come with some limitations. As mentioned previously the detection of hemozoin only occurs when the parasites are in the merozoite stage. This limits the detection time frame of the parasites vs detection in the trophozoite stage, but still provides earlier detection than current methods. Second, the vessel sizes tested thus far have only been in mice. Artifacts from deeper vessel analysis in humans may decrease the sensitivity of PAFC making the detection limit less useful than currently suggested. Although challenges still exist, PAFC may play a role in improving diagnosis of Malaria in humans.

Circulating Tumor Cells (CTCs)

Circulating tumor cells or CTCs are tumor cells that have broken off from their primary tumor and travel in the blood. These CTCs then seed distant sites resulting in metastases. Metastases cause 90% of cancer-related deaths and as such, detection of CTCs is critical to the prevention of mets. [14] Studies have shown earlier detection of CTCs improves treatment and thus longer survival times. (15) Current detection methods include RT-PCR, flow cytometry, optical sensing, cell size filtration among others. [14] These methods are limited due to the sampling size from extracted blood (~5–10 mL) which results in a CTC detection limit of ~ 10 CTC/mL. These methods take hours to days to get results which can result in delayed initiation of treatment.

PAFC may play a role in the future detection of CTCs. In order to prevent the limitation of small volume sampling through the extraction of blood from the patient, PAFC utilizes an in vivo method to monitor a larger volume of blood (i.e. the entire volume). [15] The study demonstrated monitoring a mouse aorta, they were able to visualize the entire mouse blood volume within 1 minute of detection.

CTCs such as melanomas contain an intrinsic chromophore and do not require labeling for detection above the background of hemoglobin. Other tumor cells (such as cancerous squamous cells) can be tagged with nanoparticles to produce a larger PA signal over RBCs for their detection. These methods resulted in an improved detection limit of CTCs. De la Zerda et al. detected CTCs after only 4 days with inoculation of the cancer cells. [14] Their detection limit was determined to be 1 CTC/mL, a 10 fold improvement in sensitivity. Furthermore, the nano-particle labeling was found to be non-toxic and only took 10 minutes to optimally tag the CTCs. [14]

This CTC detection can be used for metastatic screening, but also has therapeutic implications. During tumor resection or manipulation it has been determined that these manipulations release CTCs. PAFC can be used as a way to monitor for the release of these CTCs which then may require treatment in a systematic manner. Due to the non-linear thermoelastic effect from the laser on CTCs/Nanoparticles a higher laser fluence can cause the CTC to rupture without damaging the local RBCs. [16] With reduction of CTCs, this could improve treatment with systemic methods or completely remove the need altogether.

Although there is a large potential for application, there are still areas for improvement. First, PAFC is depth limited and has only been tested in superficial skin of humans which may pose a difficulty for more centrally located tumors such as lung or bowel. Second, although initial mouse models have shown efficacy with nanoparticle labeling, specific cancer type labeling and dye side-effects need to be more deeply studied to assure safety of this imaging modality.

Related Research Articles

<span class="mw-page-title-main">Microscopy</span> Viewing of objects which are too small to be seen with the naked eye

Microscopy is the technical field of using microscopes to view objects and areas of objects that cannot be seen with the naked eye. There are three well-known branches of microscopy: optical, electron, and scanning probe microscopy, along with the emerging field of X-ray microscopy.

<span class="mw-page-title-main">Medical ultrasound</span> Diagnostic and therapeutic technique

Medical ultrasound includes diagnostic techniques using ultrasound, as well as therapeutic applications of ultrasound. In diagnosis, it is used to create an image of internal body structures such as tendons, muscles, joints, blood vessels, and internal organs, to measure some characteristics or to generate an informative audible sound. The usage of ultrasound to produce visual images for medicine is called medical ultrasonography or simply sonography, or echography. The practice of examining pregnant women using ultrasound is called obstetric ultrasonography, and was an early development of clinical ultrasonography. The machine used is called an ultrasound machine, a sonograph or an echograph. The visual image formed using this technique is called an ultrasonogram, a sonogram or an echogram.

<span class="mw-page-title-main">Time of flight</span> Timing of substance within a medium

Time of flight (ToF) is the measurement of the time taken by an object, particle or wave to travel a distance through a medium. This information can then be used to measure velocity or path length, or as a way to learn about the particle or medium's properties. The traveling object may be detected directly or indirectly. Time of flight technology has found valuable applications in the monitoring and characterization of material and biomaterials, hydrogels included.

<span class="mw-page-title-main">Flow cytometry</span> Lab technique in biology and chemistry

Flow cytometry (FC) is a technique used to detect and measure the physical and chemical characteristics of a population of cells or particles.

Laser-ultrasonics uses lasers to generate and detect ultrasonic waves. It is a non-contact technique used to measure materials thickness, detect flaws and carry out materials characterization. The basic components of a laser-ultrasonic system are a generation laser, a detection laser and a detector.

<span class="mw-page-title-main">Photoacoustic imaging</span> Imaging using the photoacoustic effect

Photoacoustic imaging or optoacoustic imaging is a biomedical imaging modality based on the photoacoustic effect. Non-ionizing laser pulses are delivered into biological tissues and part of the energy will be absorbed and converted into heat, leading to transient thermoelastic expansion and thus wideband ultrasonic emission. The generated ultrasonic waves are detected by ultrasonic transducers and then analyzed to produce images. It is known that optical absorption is closely associated with physiological properties, such as hemoglobin concentration and oxygen saturation. As a result, the magnitude of the ultrasonic emission, which is proportional to the local energy deposition, reveals physiologically specific optical absorption contrast. 2D or 3D images of the targeted areas can then be formed.

Photothermal therapy (PTT) refers to efforts to use electromagnetic radiation for the treatment of various medical conditions, including cancer. This approach is an extension of photodynamic therapy, in which a photosensitizer is excited with specific band light. This activation brings the sensitizer to an excited state where it then releases vibrational energy (heat), which is what kills the targeted cells.

Acoustic microscopy is microscopy that employs very high or ultra high frequency ultrasound. Acoustic microscopes operate non-destructively and penetrate most solid materials to make visible images of internal features, including defects such as cracks, delaminations and voids.

<span class="mw-page-title-main">Thermoacoustic imaging</span>

Thermoacoustic imaging was originally proposed by Theodore Bowen in 1981 as a strategy for studying the absorption properties of human tissue using virtually any kind of electromagnetic radiation. But Alexander Graham Bell first reported the physical principle upon which thermoacoustic imaging is based a century earlier. He observed that audible sound could be created by illuminating an intermittent beam of sunlight onto a rubber sheet. Shortly after Bowen's work was published, other researchers proposed methodology for thermoacoustic imaging using microwaves. In 1994 researchers used an infrared laser to produce the first thermoacoustic images of near-infrared optical absorption in a tissue-mimicking phantom, albeit in two dimensions (2D). In 1995 other researchers formulated a general reconstruction algorithm by which 2D thermoacoustic images could be computed from their "projections," i.e. thermoacoustic computed tomography (TCT). By 1998 researchers at Indiana University Medical Center extended TCT to 3D and employed pulsed microwaves to produce the first fully three-dimensional (3D) thermoacoustic images of biologic tissue [an excised lamb kidney ]. The following year they created the first fully 3D thermoacoustic images of cancer in the human breast, again using pulsed microwaves. Since that time, thermoacoustic imaging has gained widespread popularity in research institutions worldwide. As of 2008, three companies were developing commercial thermoacoustic imaging systems – Seno Medical, Endra, Inc. and OptoSonics, Inc.

The photoacoustic Doppler effect is a type of Doppler effect that occurs when an intensity modulated light wave induces a photoacoustic wave on moving particles with a specific frequency. The observed frequency shift is a good indicator of the velocity of the illuminated moving particles. A potential biomedical application is measuring blood flow.

Ultrasound-modulated optical tomography (UOT), also known as Acousto-Optic Tomography (AOT), is a hybrid imaging modality that combines light and sound; it is a form of tomography involving ultrasound. It is used in imaging of biological soft tissues and has potential applications for early cancer detection. As a hybrid modality which uses both light and sound, UOT provides some of the best features of both: the use of light provides strong contrast and sensitivity ; these two features are derived from the optical component of UOT. The use of ultrasound allows for high resolution, as well as a high imaging depth. However, the difficulty of tackling the two fundamental problems with UOT have caused UOT to evolve relatively slowly; most work in the field is limited to theoretical simulations or phantom / sample studies.

Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging, positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.

The photoacoustic effect or optoacoustic effect is the formation of sound waves following light absorption in a material sample. In order to obtain this effect the light intensity must vary, either periodically or as a single flash. The photoacoustic effect is quantified by measuring the formed sound with appropriate detectors, such as microphones or piezoelectric sensors. The time variation of the electric output from these detectors is the photoacoustic signal. These measurements are useful to determine certain properties of the studied sample. For example, in photoacoustic spectroscopy, the photoacoustic signal is used to obtain the actual absorption of light in either opaque or transparent objects. It is useful for substances in extremely low concentrations, because very strong pulses of light from a laser can be used to increase sensitivity and very narrow wavelengths can be used for specificity. Furthermore, photoacoustic measurements serve as a valuable research tool in the study of the heat evolved in photochemical reactions, particularly in the study of photosynthesis.

Multi-spectral optoacoustic tomography (MSOT), also known as functional photoacoustic tomography (fPAT), is an imaging technology that generates high-resolution optical images in scattering media, including biological tissues. MSOT illuminates tissue with light of transient energy, typically light pulses lasting 1-100 nanoseconds. The tissue absorbs the light pulses, and as a result undergoes thermo-elastic expansion, a phenomenon known as the optoacoustic or photoacoustic effect. This expansion gives rise to ultrasound waves (photoechoes) that are detected and formed into an image. Image formation can be done by means of hardware or computed tomography. Unlike other types of optoacoustic imaging, MSOT involves illuminating the sample with multiple wavelengths, allowing it to detect ultrasound waves emitted by different photoabsorbing molecules in the tissue, whether endogenous or exogenous. Computational techniques such as spectral unmixing deconvolute the ultrasound waves emitted by these different absorbers, allowing each emitter to be visualized separately in the target tissue. In this way, MSOT can allow visualization of hemoglobin concentration and tissue oxygenation or hypoxia. Unlike other optical imaging methods, MSOT is unaffected by photon scattering and thus can provide high-resolution optical images deep inside biological tissues.

Stimulated Raman spectroscopy, also referred to as stimulated Raman scattering (SRS), is a form of spectroscopy employed in physics, chemistry, biology, and other fields. The basic mechanism resembles that of spontaneous Raman spectroscopy: a pump photon, of the angular frequency , which is scattered by a molecule has some small probability of inducing some vibrational transition, as opposed to inducing a simple Rayleigh transition. This makes the molecule emit a photon at a shifted frequency. However, SRS, as opposed to spontaneous Raman spectroscopy, is a third-order non-linear phenomenon involving a second photon—the Stokes photon of angular frequency —which stimulates a specific transition. When the difference in frequency between both photons resembles that of a specific vibrational transition the occurrence of this transition is resonantly enhanced. In SRS, the signal is equivalent to changes in the intensity of the pump and Stokes beams. The signals are typically rather low, of the order of a part in 10^5, thus calling for modulation-transfer techniques: one beam is modulated in amplitude, and the signal is detected on the other beam via a lock-in amplifier. Employing a pump laser beam of a constant frequency and a Stokes laser beam of a scanned frequency allows for unraveling the molecule's spectral fingerprint. This spectral fingerprint differs from those obtained by other spectroscopy methods, such as Rayleigh scattering, as the Raman transitions confer different exclusion rules than those that apply to Rayleigh transitions.

Super-resolution photoacoustic imaging is a set of techniques used to enhance spatial resolution in photoacoustic imaging. Specifically, these techniques primarily break the optical diffraction limit of the photoacoustic imaging system. It can be achieved in a variety of mechanisms, such as blind structured illumination, multi-speckle illumination, or photo-imprint photoacoustic microscopy in Figure 1.

<span class="mw-page-title-main">Photoacoustic microscopy</span>

Photoacoustic microscopy is an imaging method based on the photoacoustic effect and is a subset of photoacoustic tomography. Photoacoustic microscopy takes advantage of the local temperature rise that occurs as a result of light absorption in tissue. Using a nanosecond pulsed laser beam, tissues undergo thermoelastic expansion, resulting in the release of a wide-band acoustic wave that can be detected using a high-frequency ultrasound transducer. Since ultrasonic scattering in tissue is weaker than optical scattering, photoacoustic microscopy is capable of achieving high-resolution images at greater depths than conventional microscopy methods. Furthermore, photoacoustic microscopy is especially useful in the field of biomedical imaging due to its scalability. By adjusting the optical and acoustic foci, lateral resolution may be optimized for the desired imaging depth.

Deep learning in photoacoustic imaging

Deep learning in photoacoustic imaging combines the hybrid imaging modality of photoacoustic imaging (PA) with the rapidly evolving field of deep learning. Photoacoustic imaging is based on the photoacoustic effect, in which optical absorption causes a rise in temperature, which causes a subsequent rise in pressure via thermo-elastic expansion. This pressure rise propagates through the tissue and is sensed via ultrasonic transducers. Due to the proportionality between the optical absorption, the rise in temperature, and the rise in pressure, the ultrasound pressure wave signal can be used to quantify the original optical energy deposition within the tissue.

Focused-ultrasound-mediated diagnostics or FUS-mediated diagnostics are an area of clinical diagnostic tools that use ultrasound to detect diseases and cancers. Although ultrasound has been used for imaging in various settings, focused-ultrasound refers to the detection of specific cells and biomarkers under flow combining ultrasound with lasers, microbubbles, and imaging techniques. Current diagnostic techniques for detecting tumors and diseases using biopsies often include invasive procedures and require improved accuracy, especially in cases such as glioblastoma and melanoma. The field of FUS-mediated diagnostics targeting cells and biomarkers is being investigated for overcoming these limitations.

Diffuse correlation spectroscopy (DCS) is a type of medical imaging and optical technique that utilizes near-infrared light to directly and non-invasively measure tissue blood flow. The imaging modality was created by David Boas and Arjun Yodh in 1995.

References

  1. "Photoacoustic IR Spectroscopy: Instrumentation, Applications and Data Analysis, 2nd, Revised and Enlarged Edition | Wiley". Wiley.com. Retrieved 2021-12-15.
  2. 1 2 3 4 Wang LV. Photoacoustic Imaging and Spectroscopy (Optical Science and Engineering). 1st ed. Boca Raton: CRC Press; 2009.
  3. Hai, Pengfei; Zhou, Yong; Zhang, Ruiying; Ma, Jun; Li, Yang; Shao, Jin-Yu; Wang, Lihong V. (2017-04-01). "Label-free high-throughput detection and quantification of circulating melanoma tumor cell clusters by linear-array-based photoacoustic tomography". Journal of Biomedical Optics. 22 (4): 41004. Bibcode:2017JBO....22d1004H. doi:10.1117/1.JBO.22.4.041004. ISSN   1560-2281. PMC   5995136 . PMID   27832253.
  4. Ajtai, T.; Filep, Á.; Varga, A.; Motika, G.; Bozóki, Z.; Szabó, G. (2010-10-01). "Ozone concentration-monitoring photoacoustic system based on a frequency-quadrupled Nd:YAG laser". Applied Physics B: Lasers and Optics. 101 (1–2): 403–409. Bibcode:2010ApPhB.101..403A. doi:10.1007/s00340-010-4174-8. ISSN   0946-2171. S2CID   121125400.
  5. Stylogiannis, Antonios; Prade, Ludwig; Buehler, Andreas; Aguirre, Juan; Sergiadis, George; Ntziachristos, Vasilis (2018-03-01). "Continuous wave laser diodes enable fast optoacoustic imaging". Photoacoustics. 9: 31–38. doi:10.1016/j.pacs.2017.12.002. ISSN   2213-5979. PMC   5772504 . PMID   29387537.
  6. "Biggest Threats and Data | Antibiotic/Antimicrobial Resistance" Centers for Disease Control and Prevention. Retrieved 3 December 2021.
  7. 1 2 3 Edgar, Robert H.; Cook, Justin; Noel, Cierra; Minard, Austin; Sajewski, Andrea; Fitzpatrick, Matthew; Fernandez, Rachel; Hempel, John D.; Kellum, John A.; Viator, John A. (November 2019). "Bacteriophage-mediated identification of bacteria using photoacoustic flow cytometry". Journal of Biomedical Optics. 24 (11): 115003. Bibcode:2019JBO....24k5003E. doi:10.1117/1.JBO.24.11.115003. ISSN   1560-2281. PMC   6874036 . PMID   31758676.
  8. Edgar, Robert H.; Noel, Cierra; Minard, Austin; Fernandez, Rachel; Fitzpatrick, Matthew; Sajewski, Andrea; Cook, Justin; Hempel, John D.; Kellum, John A.; Viator, John A. (2019-02-27). "Identification of MRSA infection in blood using photoacoustic flow cytometry". In Wang, Lihong V; Oraevsky, Alexander A (eds.). Photons Plus Ultrasound: Imaging and Sensing 2019. Vol. 10878. SPIE. pp. 520–528. Bibcode:2019SPIE10878E..60E. doi:10.1117/12.2510210. ISBN   9781510623989. S2CID   86428267.
  9. 1 2 3 Minard A, Sajewski A, Cook J, Viator JA, Edgar RH, Hempel J, et al. "Identification of MRSA infection in blood using photoacoustic flow cytometry". In: Oraevsky AA, Wang LV, editors. Photons Plus Ultrasound: Imaging and Sensing 2019. SPIE; 2019. p. 220.
  10. "Malaria". WHO. Retrieved 19 September 2021.
  11. "Malaria - Diagnosis & Treatment (United States) - Diagnosis (U.S.)". Centers for Disease Control and Prevention. Retrieved 3 December 2021.
  12. 1 2 3 Cai, Chengzhong; Carey, Kai A.; Nedosekin, Dmitry A.; Menyaev, Yulian A.; Sarimollaoglu, Mustafa; Galanzha, Ekaterina I.; Stumhofer, Jason S.; Zharov, Vladimir P. (June 2016). "In vivo photoacoustic flow cytometry for early malaria diagnosis". Cytometry. Part A. 89 (6): 531–542. doi: 10.1002/cyto.a.22854 . ISSN   1552-4930. PMID   27078044. S2CID   3798326.
  13. 1 2 Menyaev YA, Carey KA, Nedosekin DA, Sarimollaoglu M, Galanzha EI, Stumhofer JS, et al. "Preclinical photoacoustic models: application for ultrasensitive single cell malaria diagnosis in large vein and artery". Biomed Opt Express. 2016 Sep 1;7(9):3643–58.
  14. 1 2 3 4 de la Zerda A, Kim J-W, Galanzha EI, Gambhir SS, Zharov VP. "Advanced contrast nanoagents for photoacoustic molecular imaging, cytometry, blood test, and photothermal theranostics". Contrast Media Mol Imaging. 2011 Oct;6(5):346–69.
  15. Vp, Zharov; Ei, Galanzha; Ev, Shashkov; Ng, Khlebtsov; Vv, Tuchin (2006-12-15). "In vivo photoacoustic flow cytometry for monitoring of circulating single cancer cells and contrast agents". Optics Letters. 31 (24): 3623–3625. Bibcode:2006OptL...31.3623Z. doi:10.1364/ol.31.003623. ISSN   0146-9592. PMID   17130924.
  16. Ei, Galanzha; Ev, Shashkov; Pm, Spring; Jy, Suen; Vp, Zharov (2009-10-15). "In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser". Cancer Research. 69 (20): 7926–7934. doi:10.1158/0008-5472.CAN-08-4900. ISSN   1538-7445. PMC   2828368 . PMID   19826056.